CasImg
泮托拉唑钠水合物
产品纠错
CAS号:164579-32-2 | 英文名称:PantoprazoleSodiumSesquihydrate
分子式 C16H18F2N3NaO5S
分子量 425
EINECS号 1312995-182-4
MDL MFCD16879010
Smiles
InChIKey
乙二醇化学百科
基本信息
中文名称 泮托拉唑钠水合物
英文名称 PantoprazoleSodiumSesquihydrate
CAS号 164579-32-2
分子式 C16H18F2N3NaO5S
分子量 425.38
EINECS号 1312995-182-4
物化性质
溶解度 易溶于水和乙醇(96%),几乎不溶于己烷。
形态 固体
颜色 白色至米白色
安全信息
危险品标志 Xn
危险类别码 22
WGK Germany nwg
海关编码 2933399090
生产及用途
Pantoprazole sodium hydrate (BY1023 sodium hydrate) 是一种具有口服活性的,有效质子泵 (proton pump) 抑制剂 (PPI)。Pantoprazole sodium hydrate 是一种取代的苯并咪唑,是一种有效的 H+/K+-ATPase 抑制剂,IC50 为 6.8 μM。Pantoprazo sodium hydrate 可以改善 pH 值稳定性,并具有抗分泌,抗溃疡的作用。Pantoprazo sodium hydrate 联合阿霉素 (Doxorubicin; HY-15142) 可显着增加肿瘤生长延迟。

Pantoprazole sodium hydrate (BY1023 sodium hydrate; 1-10000 μM) leads to concentration-dependent increases in endosomal pH in EMT-6 and MCF7 cells.
Pantoprazole sodium hydrate can block exosome release. Pantoprazole sodium hydrate inhibits the activity of V-H + -ATPase and impaires the ability of tumour cells (melanomas, adenocarcinomas, and lymphoma cell lines) to acidify the extracellular medium

Pantoprazole sodium hydrate (BY1023 sodium hydrate; 200 mg/kg; IP; once a week for 3 weeks) significantly increases tumor growth delay of MCF-7 xenografts combined with Doxorubicin.
Pantoprazole sodium hydrate (0.3-3 mg/kg, p.o.) dose-dependently decreases both basal acid secretion in pylorus-ligated rats and the stimulated acid secretion induced by mepirizole in acute fistula rats.

Animal Model: Mice bearing MCF-7 or A431 xenografts
Dosage: 200 mg/kg
Administration: IP; once a week for 3 weeks; alone or 2 hours before Doxorubicin (6 mg/kg i.v.)
Result: Showed even greater growth delay of MCF-7 xenografts with Doxorubicin compared with the single-dose combination.
Significantly increased tumor growth delay with a single dose with Doxorubicin.
There is no effect on growth delay alone.
上下游产品
上游产品共计:0个
下游产品共计:0个
产品供应商

首页 |  CAS目录 |  产品目录 |  企业会员 |  关于我们 |  法律声明 |  注册协议

Copyright © 冀ICP备2024096099号